Literature DB >> 9626628

Osteoclast differentiation requires ascorbic acid.

A A Ragab1, S A Lavish, M A Banks, V M Goldberg, E M Greenfield.   

Abstract

Osteoclast differentiation assays are usually conducted in alpha minimal essential medium (alpha-MEM). We reasoned that determining which components of this media are critical for osteoclast differentiation might provide insight into the mechanisms that regulate osteoclast differentiation. This study demonstrates that ascorbic acid is the crucial component of alpha-MEM that stimulates differentiation of murine osteoclasts in cocultures with murine mesenchymal support cells. Thus, supplementation with ascorbic acid allows osteoclast differentiation to occur in basal MEM media as well as in RPMI-1640 and basal media Eagle (BME) media. The conclusion that osteoclast differentiation is stimulated by ascorbic acid was obtained whether osteoclast differentiation was induced by 1,25-dihydroxyvitamin D3 or parathyroid hormone, whether ST2 or CIMC-2 cells were used as mesenchymal support cells, and whether osteoclast precursors were obtained from spleen or bone marrow. Time course studies revealed that although ascorbic acid only modestly increases the rate at which osteoclast precursors begin to express tartrate-resistant acid phosphatase, it strongly increases the rate at which precursors fuse into mature, multinucleated cells. Moreover, ascorbic acid strongly increases the life span of both osteoclasts and their precursors. The increases in precursor formation, fusion, and life span induced by ascorbic acid are together responsible for the stimulation of osteoclast differentiation by ascorbic acid. Given the known effects of ascorbic acid on differentiation of mesenchymal cells, it may stimulate osteoclast differentiation indirectly by regulating the differentiation state of the mesenchymal cells that support osteoclast differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626628     DOI: 10.1359/jbmr.1998.13.6.970

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

1.  TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival.

Authors:  Anne Gingery; Elizabeth W Bradley; Larry Pederson; Ming Ruan; Nikki J Horwood; Merry Jo Oursler
Journal:  Exp Cell Res       Date:  2008-06-13       Impact factor: 3.905

2.  A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells.

Authors:  Masako Miura; Xiao-Dong Chen; Matthew R Allen; Yanming Bi; Stan Gronthos; Byoung-Moo Seo; Saquib Lakhani; Richard A Flavell; Xin-Hua Feng; Pamela Gehron Robey; Marian Young; Songtao Shi
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

3.  Vitamin E decreases bone mass by stimulating osteoclast fusion.

Authors:  Koji Fujita; Makiko Iwasaki; Hiroki Ochi; Toru Fukuda; Chengshan Ma; Takeshi Miyamoto; Kimitaka Takitani; Takako Negishi-Koga; Satoko Sunamura; Tatsuhiko Kodama; Hiroshi Takayanagi; Hiroshi Tamai; Shigeaki Kato; Hiroyuki Arai; Kenichi Shinomiya; Hiroshi Itoh; Atsushi Okawa; Shu Takeda
Journal:  Nat Med       Date:  2012-03-04       Impact factor: 53.440

4.  Ascorbic acid inhibits osteoclastogenesis of RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand (RANKL) in vitro.

Authors:  X H Xiao; E Y Liao; H D Zhou; R C Dai; L Q Yuan; X P Wu
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

5.  A new osteopetrosis mutant mouse strain (ntl) with odontoma-like proliferations and lack of tooth roots.

Authors:  Xincheng Lu; Hector F Rios; Baichun Jiang; Lianping Xing; Renata Kadlcek; Edward M Greenfield; Guangbin Luo; Jian Q Feng
Journal:  Eur J Oral Sci       Date:  2009-12       Impact factor: 2.612

6.  Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice.

Authors:  Amelia L M Sutton; Xiaoxue Zhang; Diane R Dowd; Yogendra P Kharode; Barry S Komm; Paul N Macdonald
Journal:  Mol Endocrinol       Date:  2008-03-20

7.  Vitamin C prevents hypogonadal bone loss.

Authors:  Ling-Ling Zhu; Jay Cao; Merry Sun; Tony Yuen; Raymond Zhou; Jianhua Li; Yuanzhen Peng; Surinder S Moonga; Lida Guo; Jeffrey I Mechanick; Jameel Iqbal; Liu Peng; Harry C Blair; Zhuan Bian; Mone Zaidi
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

8.  Unique roles of phosphorus in endochondral bone formation and osteocyte maturation.

Authors:  Rong Zhang; Yongbo Lu; Ling Ye; Baozhi Yuan; Shibin Yu; Chunlin Qin; Yixia Xie; Tian Gao; Marc K Drezner; Lynda F Bonewald; Jian Q Feng
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

9.  Effect of Dietary Vitamin C on Orthodontic Tooth Movement in Rats.

Authors:  Amirfarhang Miresmaeili; Najmeh Mollaei; Ramin Azar; Nasrin Farhadian; Khosrou Mani Kashani
Journal:  J Dent (Tehran)       Date:  2015-06

Review 10.  Vitamin C Deficiency and the Risk of Osteoporosis in Patients with an Inflammatory Bowel Disease.

Authors:  Alicja Ewa Ratajczak; Aleksandra Szymczak-Tomczak; Marzena Skrzypczak-Zielińska; Anna Maria Rychter; Agnieszka Zawada; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  Nutrients       Date:  2020-07-29       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.